首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 343 毫秒
1.
非洲马瘟(African horse sickness,AHS)由非洲马瘟病毒(African horse sickness virus,AHSV)感染马科动物而引起的一种非接触性传播的虫媒病毒病,为世界动物卫生组织法定报告的动物疫病,目前主要流行于亚撒哈拉非洲等地区。库蠓(Culicoides midges)是非洲马瘟的主要媒介昆虫,其在疫区的生长繁殖直接影响着该病的流行状况。非洲马瘟弱毒苗和灭活苗已经商品化并得到广泛地应用,新型基因工程疫苗,如亚单位疫苗、活病毒载体疫苗等,正在研发当中并有望将来进入疫苗市场,作者着重对ASH疫苗的研究现状进行了评述。  相似文献   

2.
我国已被世界动物卫生组织(OIE)认可为非洲马瘟(African horse sickness,AHS)历史无疫国家.2020年泰国、马来西亚发生的AHS疫情,对我国防范AHS传入带来了极大压力.为有效防止AHS传入,基于OIE风险分析框架,利用OIE风险评估矩阵,从传入评估、暴露评估和后果评估三个角度,分析进境马匹传...  相似文献   

3.
为建立非洲马瘟病毒(African Horse Sickness Virus,AHSV)的血清学诊断方法,本研究构建了非洲马瘟病毒VP7蛋白的原核表达质粒pET-32a-VP7,诱导表达后使用Ni-NTA对可溶性VP7蛋白亲和纯化,以重组VP7蛋白作为包被抗原,优化建立检测血清抗体的间接ELISA方法,并对该方法进行敏感性、特异型和重复性验证,表明该方法的检测效果良好。本研究为非洲马瘟的血清检测试剂盒的开发提供的相关参考。  相似文献   

4.
正北京时间2020年3月27日,泰国农业与合作部向世界动物卫生组织(World Organization for Animal Health,OIE)通报了该国发生的非洲马瘟(African horse sickness,AHS)疫情。根据OIE网站信息,该起非洲马瘟暴发于泰国东北部的呵叻省,以巴冲区域为疫情中心。疫情时间起始于2020年2月24日,通报时已经至少影响到341匹易感马匹,其中62匹发病,42匹死亡。  相似文献   

5.
为建立非洲马瘟病毒(AHSV)可视化RT-LAMP检测方法,本研究根据AHSV外衣壳蛋白(VP7)基因保守序列设计2对特异性引物,通过反应条件优化建立了AHSV可视化RT-LAMP检测方法。结果显示,本实验所建立RT-LAMP方法的最佳反应条件为62℃1 h;利用该方法检测进口灭活冻干疫苗中的9个血清型AHSV以及马流感病毒、马传贫病毒、马动脉炎病毒和蓝舌病病毒的RNA,结果显示所有血清型AHSV RNA检测均为阳性,其它病毒RNA检测为阴性,该方法特异性较强;该方法最低可检测到3.2×10~(-9)ng/μL的RNA,敏感性是普通RT-PCR方法的1 000倍。利用建立的RT-LAMP方法和普通RT-PCR方法对35份马血和5份驴血样品同时进行检测,结果显示二者阳性和阴性符合率均为100%。本研究在国内外首次建立了AHSV 9种血清型的可视化RT-LAMP检测方法,其具有特异性强、敏感性高、快速和高通量检测的优点,为非洲马瘟(AHS)快速的可视化现场诊断提供可行方法。  相似文献   

6.
正2018年8月我国首起非洲猪瘟(ASF)疫情发生,而非洲马瘟(AHS)尚未在我国发生。当前世界贸易开放化程度加大,流动性加强,且针对非洲猪瘟和非洲马瘟尚无有效药物治疗,我国各相关部门对其均保持了高度警惕。本文对比分析了非洲猪瘟与非洲马瘟的概念、生存共性、传播区别等特征,结合我国非洲马瘟的入境防控、疫苗使用、疫情制度完善、区域排查等现有的一系列  相似文献   

7.
VP7蛋白是非洲马瘟病毒(AHSV)群特异性蛋白,其编码基因S7基因常被用作AHSV RT-PCR和实时荧光RT-PCR检测的靶标基因。本研究旨在构建耐RNase的内含AHSV部分核酸序列的病毒样颗粒。首先合成S7基因保守序列,然后克隆到含有噬菌体包膜蛋白基因的带组氨酸纯化标签的假病毒表达载体pNH-MS2his上,成功构建原核表达载体pNH-MS2his-VP7。将重组质粒pNH-MS2his-VP7转化BL21(DE3),并进行诱导表达及镍离子亲和层析纯化后,得到含AHSV部分RNA片段的病毒样颗粒。试验证实该病毒样颗粒均匀性和稳定性良好,可作为AHSV PCR检测的质控品和标准品使用。  相似文献   

8.
为了建立非洲马瘟病毒(AHSV)环介导等温扩增(loop-mediated isothermal amplification,LAMP)快速检测方法,基于AHSV VP7基因保守序列,设计2对特异性扩增引物。通过对反应体系中各组分浓度,反应温度及时间的优化,建立了快速、灵敏的AHSV RT-LAMP检测方法,并对该方法特异性、灵敏度、重复性进行探索。结果表明,在63℃恒温下反应45min,便可进行高效率的特异性扩增。反应产物经琼脂糖凝胶电泳和染料可视化鉴定,能够快速有效检测AHSV。用建立的方法检测马属动物易感的4种疫病病原,结果均为阴性,证实具有较高的特异性。灵敏度是RT-PCR的1 000倍。建立了AHSV RT-LAMP检测方法,具有快速、特异、灵敏、操作简单、设备要求低的特点,适合用于现场AHSV快速检测。  相似文献   

9.
为建立检测非洲马瘟间接酶联免疫吸附试验方法,利用重组杆状病毒感染昆虫细胞表达出具有良好抗原性的VP7蛋白,将感染VP7重组杆状病毒的昆虫细胞裂解液作为包被抗原,通过优化包被抗原浓度、二抗稀释度等,建立了检测非洲马瘟的间接ELISA方法,并进行了初步运用。结果表明,直接利用真核细胞表达VP7蛋白的昆虫细胞裂解液作为包被液可成功建立检测非洲马瘟的间接ELISA方法。  相似文献   

10.
非洲马瘟(AHS)病毒可在马属动物中引起一种非接触传染性、节肢动物源性疾病。该病在易感马群中常常造成毁灭性的损失,其死亡率高达95%以上。AHS已被公认的血清型有9个,这些血清型在非洲均有流行。此外,印度、中东和南欧等地也有该病的严重流行(Rafyi,1961)。除了最近在西班牙、葡萄牙和摩洛哥发生的AHS暴发是由4型AHS病毒引起的之  相似文献   

11.
12.
A highly sensitive and specific TaqMan-MGB real-time RT-PCR assay has been developed and standardised for the detection of African horse sickness virus (AHSV). Primers and MGB probe specific for AHSV were selected within a highly conserved region of genome segment 7. The robustness and general application of the diagnostic method were verified by the detection of 12 AHSV isolates from all of the nine serotypes. The analytical sensitivity ranged from 0.001 to 0.15 TCID50 per reaction, depending on the viral serotype. Real-time PCR performance was preliminarily assessed by analysing a panel of field equine samples. The same primer pair was used to standardise a conventional RT-PCR as an affordable, useful and simple alternative method in laboratories without access to real-time PCR instruments. The two techniques present novel tools to improve the molecular diagnosis of African horse sickness (AHS).  相似文献   

13.
采用人工拼接的方式拼接了非洲马瘟病毒(AHSV)含有绝大多数线性抗原表位的VP7编码基因片段,克隆于pET-30a构建重组质粒pET-30a-VP7,将pET-30a—VP7转化BL21(DE3),经1.0mmol/LIPTG诱导,外源基因以包涵体的形式获得高效表达。通过Dot-EuSA以及ELISA试验证明表达产物具有良好的反应原性。以纯化后表达产物作为诊断抗原包被酶标板建立了检测AHSV抗体的间接ELISA方法。结果表明,抗原的最佳包被浓度为0.25μg/mL,血清的最佳稀释度为1:40,待检血清阳性临界值初步定为0.25。用此方法和商品化ELISA试剂盒检测了184份血清样品,结果完全符合。  相似文献   

14.
15.
African horse sickness virus structure   总被引:4,自引:0,他引:4  
African horse sickness virus (AHSV), of which there are nine serotypes (AHSV-1, -2, etc.), is a member of Orbivirus genus within the Reoviridae family. Both in morphology and molecular constituents AHSV particles are comparable to those of bluetongue virus (BTV), the prototype virus of the genus. The two viruses have seven structural proteins (VP1–7) organized in two layered capsid. The outer capsid is composed of VP2 and VP5. The inner capsid, or core, is composed of two major proteins, VP3 and VP7, and three minor proteins, VP1, VP4 and VP6. Within the core is the virus genome. This genome consists of 10 double-stranded (ds)RNA segments of different sizes, three large, designated L1–L3, three medium, M4–M6, and four small, S7–S10. In addition to the seven stuctural proteins that are coded by seven of the RNA species, four non-structural proteins, NS1, NS2, NS3 and NS3A, are coded by three RNA segments, M5, S8 and S10. The two smallest proteins (NS3 and NS3A) are synthesized by the S10 RNA segment, probably from different in-frame translation initiation codons. Nucleotide sequences of eight RNA segments (L2, L3, M4, M5, M6, S7, S8 and S10) and the predicted amino acid sequences of the encoded gene products are also available, mainly representing one serotype, AHSV-4. In this review the properties of the AHSV genes and gene products are discussed. The sequence and hybridization analyses of the different AHSV dsRNA segments indicate that the segments that code for the core proteins, as well as those that code for NS1 and NS2 proteins, are highly conserved between the different virus serotypes. However, the RNA encoding NS3 and NS3A, and the two segments encoding the outer capsid proteins, are more variable between the AHSV serotypes. A close phylogenetic relationship between AHSV, BTV and epizootic haemorrhagic disease virus (EHDV), three Culicoides-transmitted orbiviruses, has been revealed when the equivalent sequences of genes and gene products are compared. Recently, the four major AHSV capsid proteins have been expressed using recombinant baculoviruses. Biochemically and antigenically these proteins are similar to the authentic proteins. Since the AHSV VP7 protein is highly conserved among the different serotypes, it has been utilized as a diagnostic reagent. The expressed VP7 protein has also been purified to homogeneity and crystallized for three-dimensional X-ray analysis. The expressed outer capsid proteins, VP2 and VP5, have been purified and used to raise antisera in rabbits. The VP2 antisera neutralize virus infections in vitro indicating the importance of this protein for vaccine development.  相似文献   

16.
Four polyethylene glycol-mediated cell fusions yielded a total of 23 monoclonal antibodies (McAbs) specific for African horsesickness virus (AHSV). Two recognised the major core structural polypeptide, VP7, while one each was specific for the outer capsid proteins, VP2 and VP5. The remainder co-precipitated both VP2 and VP7. An inhibition ELISA and radio-immunoprecipitation revealed two types of co-precipitating McAbs, distinguishable from each other by the different relative amounts of the two proteins they precipitated. Only co-precipitating McAbs reduced the size and number of plaques formed by AHSV on VERO cell monolayers, but even at low dilution did not completely abolish virus infectivity. A McAb specific for VP7 showed potential as a group-reactive diagnostic reagent since guinea pig antisera to all nine serotypes of AHSV, as well as an anti-serotype 4 horse serum and an anti-serotype 3 rabbit serum, inhibited its binding in ELISA to AHSV serotype 3.  相似文献   

17.
A recombinant canarypox virus vectored vaccine co-expressing synthetic genes encoding outer capsid proteins, VP2 and VP5, of African horse sickness virus (AHSV) serotype 4 (ALVAC(?)-AHSV4) has been demonstrated to fully protect horses against homologous challenge with virulent field virus. Guthrie et al. (2009) detected weak and variable titres of neutralizing antibody (ranging from <10 to 40) 8 weeks after vaccination leading us to hypothesize that there could be a participation of cell mediated immunity (CMI) in protection against AHSV4. The present study aimed at characterizing the CMI induced by the experimental ALVAC(?)-AHSV4 vaccine. Six horses received two vaccinations twenty-eight days apart and three horses remained unvaccinated. The detection of VP2/VP5 specific IFN-γ responses was assessed by enzyme linked immune spot (ELISpot) assay and clearly demonstrated that all ALVAC(?)-AHSV4 vaccinated horses developed significant IFN-γ production compared to unvaccinated horses. More detailed immune responses obtained by flow cytometry demonstrated that ALVAC(?)-AHSV4 vaccinations induced immune cells, mainly CD8(+) T cells, able to recognize multiple T-epitopes through all VP2 and only the N-terminus sequence of VP5. Neither VP2 nor VP5 specific IFN-γ responses were detected in unvaccinated horses. Overall, our data demonstrated that an experimental recombinant canarypox based vaccine induced significant CMI specific for both VP2 and VP5 proteins of AHSV4.  相似文献   

18.
本文对非洲马瘟的病毒特性、临床症状和检测方法进行概述,重点对非洲马瘟的传统疫苗和新型疫苗的研究进展进行了详细综述,以期为非洲马瘟疫苗的相关研究提供参考。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号